Total planned funding: $650,489,619
Clear active filters
Ethiopia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Ethiopia | $650,489,619 |
Organizational Types
Unknown | $146,890,328 |
Private Contractor | $119,085,332 |
Host Country Government Agency | $103,377,512 |
NGO | $94,219,543 |
University | $61,291,102 |
Own Agency | $49,916,393 |
Implementing Agency | $49,007,045 |
Multi-lateral Agency | $18,274,154 |
Other USG Agency | $5,500,265 |
FBO | $2,927,945 |
Program Areas
Treatment | $204,139,071 |
Care | $155,924,379 |
Prevention | $118,603,989 |
Governance and Systems | $98,775,471 |
Testing | $38,117,302 |
Management and Operations | $34,929,407 |
Budget Codes
HTXS: Treatment: Adult Treatment | $171,637,553 |
HBHC: Care: Adult Care and Support | $65,946,991 |
HVOP: Sexual Prevention: Other Sexual Prevention | $64,857,425 |
HKID: Care: Orphans and Vulnerable Children | $61,145,261 |
OHSS: Health Systems Strengthening | $46,664,684 |
HVCT: Testing: HIV Testing and Counseling | $38,117,302 |
HVMS: Management and Operations | $34,929,407 |
HVSI: Strategic Information | $31,793,083 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $31,733,330 |
HLAB: Laboratory Infrastructure | $20,317,704 |
HVTB: Care: TB/HIV | $18,934,573 |
PDTX: Treatment: Pediatric Treatment | $16,749,853 |
HTXD: Treatment: ARV Drugs | $15,751,665 |
PDCS: Care: Pediatric Care and Support | $9,897,554 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,759,921 |
HMIN: Biomedical Prevention: Injection Safety | $7,227,118 |
HMBL: Biomedical Prevention: Blood Safety | $4,381,744 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,644,451 |
Top Partner Programs
Not Available:
$141,998,282
Countries/Regions
Chemonics International:
$47,644,297
Countries/Regions
Columbia University:
$45,358,804
Countries/Regions
USG Aggregated Agencies:
$42,227,947
Countries/Regions